Farmacogenetics as a tool for clinical decision-making on refractory schizophrenia
Association between genetic polymorphisms of dihydropyrimidine dehydrogenase enzym...
Cisplatin-induced nephrotoxicity: contribution of clinical, genetic and epigenetic...
Employing human oligodendroglial cell cultures and glutamatergic dysfunction to un...
Pharmacogenomic and pharmacoepigenomic analysis in individuals with familial hyper...
Relationship between polymorphisms in the ABCB1 e ABCB2 genes as major toxicities ...
Employing CRISPR/Cas9 and Saccharomyces cerevisiae to understand energetic aspects...